[In vitro effect of 1-hexylcarbamoyl-5-fluorouracil on human cancer cell lines of gastrointestinal tract]. 1993

M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
Dept. of Surgery II, Nagoya University School of Medicine.

UI MeSH Term Description Entries
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
October 1987, European journal of cancer & clinical oncology,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
February 1999, International journal of oncology,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
October 1980, Gan,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
March 1989, European journal of cancer & clinical oncology,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
January 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
September 1978, Xenobiotica; the fate of foreign compounds in biological systems,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
November 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
June 1981, Cancer treatment reviews,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
February 1981, Journal of the National Cancer Institute,
M Kataoka, and S Akiyama, and S Kawasaki, and T Sato, and S Asai, and T Satta, and E Takeshima, and K Kondo, and M Yamauchi, and K Ito
July 1981, Journal of pharmacobio-dynamics,
Copied contents to your clipboard!